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terminal region. This helix has been thought to help to coordinate
conformational changes by linking discontinuous TM helices between
the antiporters. Here, we introduced alanine-substitution mutation into
eight residues; MrpA-D77, MrpA-R262, MrpA-G311, MrpA-F357, MrpD-
D75, MrpD-D258, MrpD-G309, MrpD-F341 residues conserved in all
MrpA, MrpD, NuoLMN to probe their roles in function and structure
impact of MrpA andMrpD. Onlymutations inMrpD, in residues it shares
with MrpA, showed effects in function or complex formation, while no
signiﬁcant phenotypes were detectable in the mutants at corresponding
residues in MrpA. We previously reported that MrpD is essential for
expression of other Mrp subunits in the cytoplasmic membrane [1].
These data suggest thatMrpDoccupies primary position inMrp complex.
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Mitochondrial complex I (NADH:ubiquinone oxidoreductase) is an
entry point of electrons into the respiratory chain. It oxidizes NADH,
reduces quinone, and couples the redox process to proton translocation
across the innermitochondrialmembrane. Numerous diseases have been
reported to arise from defects in complex I, ranging from muscular to
neurodegenerative diseases [1]. Complex I has a unique L-shaped
structure, containing 14 conserved ‘core’ subunits that have been
identiﬁed in bacteria to eukaryotes [2]. Complex I from bovine heart has
been used as a mammalian enzyme model for complex I studies, and 30
additional ‘supernumerary’ subunits have been identiﬁed in it [2].
However, it is not known how the subunit compositions of complex I
from different mammalian tissues may vary. Rat (Rattus norvegicus) is a
popular in vivo model for studying mitochondrial dysfunction and other
diseases, providing a model for comparison of various tissues to study
complex I using minimum materials. Here, tissues were obtained from
the rat skeletal muscle, heart, kidney, liver and brain and used to prepare
mitochondria and purify complex I. As there is no published protocol for
obtaining highly-pure catalytically-active complex I from rat tissues, the
standard bovine heart complex I isolation protocol was used initially [3],
andmodiﬁed to suit the small scale puriﬁcation. Amicroscale puriﬁcation
system consisting of three chromatographic steps was applied in order to
obtain the best resolution, recovery and purity from small amounts of
material (down to 0.5 g tissue). The catalytic activities were assessed and
the polypeptide composition of each complex I from each tissue was
identiﬁed and compared by mass spectrometry.
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The reaction mechanism of mitochondrial NADH–quinone oxidore-
ductase (complex I) is thought to involve dynamic conformational
changes in the membrane domain including the quinone catalytic site.
The site-speciﬁc chemical modiﬁcation of complex I by various
functional probes such as ﬂuorophores, without affecting the enzyme
activity, would allow single-molecule analyses of putative conforma-
tional changes of the enzyme. To address this challenge, we tried site-
speciﬁc alkynylation of complex I in bovine heart submitochondrial
particles (SMP) through ligand-directed tosylate (LDT) chemistry using a
synthetic high afﬁnity ligand (acetogenin ligand 1), which has an
alkynylated tosylate in the tail moiety. The terminal alkyne in ligand 1
was chosen as the tag to be incorporated into the enzyme since this
functional group canwork as a “footing” for subsequent diverse chemical
modiﬁcations via click chemistry (i.e. azide-alkyne [3 + 2] cycloaddition
inwater).We carried out the alkynylation of complex I via LDT chemistry
by incubating bovine SMP with ligand 1 for 24 h at 35 °C. To identify the
alkynylated position by ligand 1, ﬂuorescent TAMRA and/or biotin were
covalently attached to the incorporated alkyne by click chemistry after
the solubilization of complex I. Careful proteomic analyses showed that
the alkynylation occurred at Asp160 in the 49 kDa subunit, which may
be located in the putative quinone binding cavity. The alkynylation was
completely suppressed by an excess amount of other inhibitors binding
to the quinone cavity such as bullatacin and quinazoline. While the
reaction yield of the alkynylation step was estimated to be ~50%, the
alkynylation unfortunately resulted in the almost complete loss of the
enzyme activity. Nevertheless, the results of our work demonstrate that
complex I can be site-speciﬁcally alkynylated through LDT chemistry,
providing a positive clue to diverse chemical modiﬁcations of the
enzyme in combination with click chemistry.
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Ohnishi and coworkers characterized complex I redox centers,
identiﬁed two distinct protein-associated ubisemiquinone, SQNf and SQNs,
Abstractse46
and proposed the involvement of the SQNf site in energy transduction (1).
SQNf is extremely sensitive to transmembrane proton electrochemical
potential. SQNsmay function as a 1/2e− transfer converter, andmight be a
binding site to pool UQ. We determined N2⇔ SQNf and N2⇔ QNs
distances as 12 Å and 30 Å, respectively, based on analysis of their spin
coupling. The current consensus total H+-pumping stoichiometry for
complex I is (4H+/2e−). In our proposal (1), (2H+/2e−) stoichiometry is
directly coupled with redox reaction and (2H+/2e−) stoichiometry is
simultaneously via indirect protonpump, adopting suggestions by several
groups (2,3).Sazanov and colleagues published a long-awaited structure
of nearly complete complex I in 2010, missing only the NuoH subunit at
the junction of the membrane and hydrophilic arm. In 2013, the same
group published the structure of the entire complex I, including NuoH,
which deﬁned a “unique quinone reaction chamber” (3). Good evidence
was obtained for a Q-binding site located at the top of the chamber,
exactly the same distance from N2 to QNf. The position for Q entry is
consistent with the distance we measured between QNs and N2. They
proposed a ‘piston-like’ structure driving proton pumping via a long-
range conformational change. In Sazanov's model, (3H+/2e−) stoichiom-
etry is supplied by antiporter homologs (2), leaving (1H+/2e−) for
quinone-linked translocation.We present an alternative proton pumping
model consistent with homology, diffraction, and spectroscopic
information.
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Respiratory complex I (E.C.1.6.5.3) is amembrane-bound enzyme that
has an essential function in cellular energy production. It couples NADH:
quinone oxidoreduction to translocation of ions across the cellular
(in prokaryotes) or mitochondrial membranes. Therefore, complex I
contributes to the establishment andmaintenance of the transmembrane
difference of electrochemical potential required for ATP synthesis,
transport and motility.
We have developed a strategy for reconstituting the bacterial
complex I from Rhodothermus marinus, keeping its structural and
functional properties, onto a biomimetic membrane supported on
gold electrodes modiﬁed with a thiol self-assembled monolayer
(SAM). Atomic force microscopy and faradaic impedance measure-
ments give evidence of the biomimetic construction, whereas
electrochemical measurements show its functionality. Both electron
transfer and proton translocation by respiratory complex I were
monitored, simulating in vivo conditions. Reconstitution of the
respiratory complex I, in its native form on supported biomimetic
membranes allows performing many fundamental studies about its
function in cellular energy production.
doi:10.1016/j.bbabio.2014.05.066
S4.P19
Characterization of the piericidin binding site of Escherichia coli
NADH:ubiquinone oxidoreductase
Ina Psarjowa, Katharina Maurera, Stefan Steimleb, Thorsten Friedrichc
aInstitut für Biochemie Universität Freiburg, Germany
bInstitute of Biochemistry, Albert Ludwigs University Freiburg, Germany
cAlbert-Ludwigs-Universitat Freiburg, Germany
E-mail address: psarjow@bio.chemie.uni-freiburg.de
The NADH:ubiquinone oxidoreductase, complex I, is the ﬁrst
and largest enzyme of the respiratory chains. It couples the electron
transfer from NADH to ubiquinone with a proton translocation
across the membrane. The mechanism of ubiquinone (Q) binding
and reduction is still unknown. Recently, the structure of the
Thermus thermophilus complex I with co-crystallized/soaked decyl-
ubiquinone and piericidin, a speciﬁc Q-site inhibitor, gave a ﬁrst
impression on the binding of ubiquinone. Tyr273 and His224 on
subunit NuoCD of the Escherichia coli complex I are supposed to
interact with the carbonyl groups of Q, while piericidin only
interacts with Y273. It was shown by site-directed mutagenesis
that Tyr273 is essential for the activity in mitochondrial complex I
from Yarrowia lipolytica. We exchanged the tyrosine with several
amino acids and the histidine to methionine, isolated the variants
and determined their activity and the inhibition by piericidin. The
mutation Y273FCD resulted in a more than two-fold higher IC50 to
piericidin, while that of Y273HCD variant did not change. Thus, the
hydroxyl group of Y273CD participates in piericidin binding in E. coli
complex I. The IC50 of the H224MCD variant was signiﬁcantly
reduced, implying that H224CD involved in piericidin binding via a
hydrogen network within the active site.
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Complex I (NADH:ubiquinone oxidoreductase) is the ﬁrst and
largest enzyme in the respiratory chain. This is the major contributor
to the establishment and maintenance of the electrochemical
potential required for ATP synthesis. Although the high resolution
structure of complex I has been determined, the mechanism behind
its catalytic activity is still not completely understood.
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